Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety of Oral Ritlecitinib for the Treatment of Active Nonsegmental Vitiligo: A Randomized Phase 2b Clinical Trial.

Khaled Ezzedine,Elena Peeva,Yuji Yamaguchi,Lori Ann Cox,Anindita Banerjee,George Han,Iltefat Hamzavi,Anand K Ganesan,Mauro Picardo,Diamant Thaçi,John E Harris,Jung Min Bae,Katsuhiko Tsukamoto,Rodney Sinclair,Amit G Pandya,Abigail Sloan,Dahong Yu,Kavita Gandhi,Michael S Vincent,Brett King

Journal of the American Academy of Dermatology（2022）

Cited 12|Views55
No score
Abstract
Oral ritlecitinib was effective and well-tolerated over 48 weeks in patients with active NSV.
More
Translated text
Key words
JAK inhibitor,JAK/STAT signaling,TEC inhibitor,VASI,Vitiligo,randomized clinical trial,ritlecitinib,skin depigmentation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined